TR
Terumo Corporation
TRUMY · OTC
$14.59 +1.81% (+$0.26)
1M -12.48%
Market Cap ¥3.28T
P/E Ratio 19.71x
Div. Yield 1.20%
ROE 10.70%
Bulios Fair Price
$8.98
38.5% downside
Trenutna cena
$14.59
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TRUMY trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
68 /100
Cheap EV/EBITDA 11.20x
P/S 2.72x
P/B 1.97x
Growth
81 /100
Growing Rev. growth 13.79%
FCF growth 24.00%
Book val. growth 10.57%
Profitability
85 /100
Strong Net margin 13.81%
Op. margin 16.90%
FCF margin 16.16%
Quality
46 /100
Average ROE 10.70%
ROA 7.00%
Asset turnover 0.51x
Debt
100 /100
Low Current ratio 2.19x
Int. coverage 56.58x
Net debt/EBITDA 0.41x
Stability
77 /100
Stable Rev. volatility 2.44%
EPS volatility 9.41%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TRUMY
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Hikaru Samejima
Employees
30,207
Headquarters
Tokyo
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report